PRME
Prime Medicine, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -11.1% ·
aandelenstroom -7.8% ·
netto nieuwe posities -12.5%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +1 | 62.51M | $230.64M | +6 | −5 |
| Q1 2026 | 80 | +2 | 55.31M | $192.04M | +9 | −7 |
| Q4 2025 | 78 | 0 | 56.37M | $195.61M | +1 | −1 |
| Q3 2025 | 18 | +3 | 30.74M | $170.29M | +3 | — |
| Q2 2025 | 12 | +1 | 18.57M | $45.87M | +1 | — |
| Q1 2025 | 8 | 0 | 10.06M | $20.03M | +1 | −1 |
| Q4 2024 | 8 | -1 | 11.48M | $33.53M | +2 | −3 |
| Q3 2024 | 8 | -1 | 11.29M | $43.71M | +1 | −2 |
| Q2 2024 | 9 | — | 11.11M | $57.12M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 5.15M | -9.0% | $15.04M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Millennium Management ✦ | 1.87M | -14.7% | $5.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.58M | +2.5% | $4.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.58M | +2.5% | $4.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.47M | +7.9% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 1.47M | +7.9% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 1.15M | — | $3.37M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 166.20K | -47.8% | $485,301 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 68.53K | Nieuw | $200,102 | 0.0% | New | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 16.05K | Nieuw | $46,854 | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 16.05K | Nieuw | $46,854 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 16.05K | Nieuw | $46,854 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $200,102 | 0.0% |
| AQR Capital Management | $46,854 | 0.0% |
| AQR Capital Management | $46,854 | 0.0% |
| AQR Capital Management | $46,854 | 0.0% |
Verlaten
| D. E. Shaw & Co. | $539,675 | was 0.0% |
| Citadel Advisors | $197,351 | was 0.0% |
| Renaissance Technologies | $77,400 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 189 houders, 97.53M aandelen, $314.58M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.